{
  "image_filename": "table_p7_det_6_004.png",
  "image_path": "Hsiao_et_al.__2023_/extracted/figures/table_p7_det_6_004.png",
  "image_type": "Table",
  "page_number": 7,
  "block_id": "det_6_004",
  "claim_id": "claim_006",
  "claim": "Flublok is produced using a novel production platform in which recombinant HA is expressed in insect cells using a baculovirus expression vector system (BEVS).",
  "supports_claim": false,
  "explanation": "A table listing demographic and clinical characteristics of participants in two vaccine groups (Recombinant Vaccine vs. Standard-Dose Vaccine) and all vaccinees, including sex, race/ethnicity, coexisting illnesses, and prior influenza vaccination status. does not support the claim, as the table provides participant demographics and clinical history but contains no information on Flublok production methods, recombinant HA expression, insect cells, or BEVS",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "A table listing demographic and clinical characteristics of participants in two vaccine groups (Recombinant Vaccine vs. Standard-Dose Vaccine) and all vaccinees, including sex, race/ethnicity, coexisting illnesses, and prior influenza vaccination status.",
    "evidence_found": null,
    "reasoning": "does not support the claim, as the table provides participant demographics and clinical history but contains no information on Flublok production methods, recombinant HA expression, insect cells, or BEVS",
    "confidence_notes": null
  }
}